Literature DB >> 8513820

Killing kinetics of cefuroxime against Streptococcus pneumoniae in an in vitro model simulating serum concentration profiles after intramuscular administration.

E Bingen1, C Doit, R Farinotti, N Lambert-Zechovsky.   

Abstract

The killing kinetics of cefuroxime against 25 Streptococcus pneumoniae isolates with penicillin MICs of < 0.1, 0.1-1.0 and 2 mg/l were studied in an in vitro model simulating the serum concentration profile in healthy adults following a single intramuscular injection of 500 mg. Cefuroxime was bactericidal against the isolates with exquisite or slightly diminished susceptibility to penicillin (-4 and -3.9 log10 cfu/ml killing, respectively) during the 6 h incubation period. In contrast, there was only a 2.8 log10 cfu/ml reduction in the initial inoculum of six of the eight isolates resistant to penicillin (MIC 2 mg/l). The two remaining penicillin-resistant isolates (cefuroxime MIC 8 mg/l) only showed a 2 log10 cfu reduction in the initial inoculum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8513820     DOI: 10.1007/BF01967263

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  10 in total

1.  PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA.

Authors:  R AUSTRIAN; J GOLD
Journal:  Ann Intern Med       Date:  1964-05       Impact factor: 25.391

2.  Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990.

Authors:  P Geslin; A Buu-Hoi; A Frémaux; J F Acar
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

Review 3.  Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae.

Authors:  M R Jacobs
Journal:  Clin Infect Dis       Date:  1992-07       Impact factor: 9.079

4.  Bactericidal activity of daptomycin against vancomycin-resistant Enterococcus faecium in an in vitro pharmacokinetic model.

Authors:  E Bingen; C Doit; N Lambert-Zechovsky; M Tod; O Petitjean; F Bourgeois; P Mariani-Kurkdjian
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-12       Impact factor: 3.267

5.  Cefuroxime: human pharmacokinetics..

Authors:  R D Foord
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

Review 6.  Cefuroxime axetil.

Authors:  M A Marx; W K Fant
Journal:  Drug Intell Clin Pharm       Date:  1988-09

7.  Community-acquired pneumonia due to penicillin-resistant pneumococci.

Authors:  C Feldman; J M Kallenbach; S D Miller; J R Thorburn; H J Koornhof
Journal:  N Engl J Med       Date:  1985-09-05       Impact factor: 91.245

8.  New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.

Authors:  S Grasso; G Meinardi; I de Carneri; V Tamassia
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

9.  Killing kinetics of cefuroxime axetil against Haemophilus influenzae in an in-vitro model simulating serum concentration profiles after oral administration.

Authors:  E Bingen; N Lambert-Zechovsky; C Doit; P Duvignaud; D Georges; P Mariani-Kurkdjian
Journal:  J Antimicrob Chemother       Date:  1991-10       Impact factor: 5.790

10.  Pneumococcal bacteraemia: 325 episodes diagnosed at St Thomas's Hospital.

Authors:  W R Gransden; S J Eykyn; I Phillips
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-16
  10 in total
  3 in total

1.  Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.

Authors:  K Tateda; K Takashima; H Miyazaki; T Matsumoto; T Hatori; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

2.  Killing activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.

Authors:  F Fitoussi; C Doit; A Sandin; A Pechinot; A Kazmierczack; P Geslin; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

3.  Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.

Authors:  J E Conte; J Golden; S Duncan; E McKenna; E Lin; E Zurlinden
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.